Prevalence of Xpert MTB/RIF Ultra Trace Call Results and Associated Risk Factors During Active Tuberculosis Case Finding in Viet Nam: A Programmatic Evaluation

Luong Van Dinh, Khoa Tu Tran, Andrew James Codlin, Luan Nguyen Quang Vo, Nga Thuy Thi Nguyen, Lan Phuong Nguyen, Rachel Forse, Han Thi Nguyen, Thi Minh Ha Dang, Lan Huu Nguyen, Hoa Binh Nguyen, and Jacob Creswell

Improving tuberculosis diagnosis in South Africa’s private sector: The results of a pilot public-private mix intervention in eThekwini health distric

Jody Boffa, Tsholofelo Mhlaba, Buyisile Chibi, Mergan Naidoo, Keeren Lutchminarain, Khine Swe Swe-Han, Jeremiah Chikovore, William Mapham, Sizulu Moyo

Community referral for presumptive TB in Nigeria: a comparison of four models of active case finding

A. O. Adejumo, B. Azuogu, O. Okorie, O. M. Lawal, O. J. Onazi, M. Gidado, O. J. Daniel, J. C. Okeibunor, E. Klinkenberg, E. M. H. Mitchell

Step Up for TB report 2024

Engaging private providers to enhance tuberculosis detection and notification: evidence from TB REACH-Supported projects

Md. Toufiq Rahman, William A. Wells, Oriol Ramis, Vishnu V. Kamineni, Mirjam I. Bakker, Sode Matiku, Miranda Brouwer & Jacob Creswell

ITB-Iplus/GDF-MED/2025/1_ITB document Revision 1

Q&A ITB-Iplus/GDF-MED/2025/1

ITB-Iplus/GDF-MED/2025/1_Annex L. TB medicines target prices

ITB-Iplus/GDF-MED/2025/1_Annex K. Form for Requests for Clarifications or Complaints

ITB-Iplus/GDF-MED/2025/1_Annex J. Global Drug Facility artwork development guidelines